The negative predictive value of breast Magnetic Resonance Imaging in noncalcified BIRADS 3 lesions

References 

1. Barlow WE, Lehman CD, Zheng Y, et al. Performance of diagnostic mammography for women with signs or symptoms of breast cancer. J Natl Cancer Inst. 2002;94(15):1151–1159
   • MEDLINE
2. Carney PA, Miglioretti DL, Yankaskas BC, et al. Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med. 2003;138(3):168–175
3. American College of Radiology (ACR). Illustrated breast imaging reporting and data system (BI-RADS); 1998.
4. Nationale Borstkanker Overleg Nederland; NABON versie 1.1; typ: landelijke richtlijn; 2009.
5. Agency for Health Care Research and Quality. Effectiveness of non-invasive diagnostic test for breast abnormalities. AHRQ publication no. 06-EHC005-EF, 2006; 2009.
6. Kerlikowske K, Grady D, Barclay J, Sickles EA, Ernster V. Likelihood ratios for modern screening mammography. Risk of breast cancer based on age and mammographic interpretation. J Am Med Assoc. 1996;276(1):39–43
7. Meyer JE, Eberlein TJ, Stomper PC, Sonnenfeld MR. Biopsy of occult breast lesions. Analysis of 1261 abnormalities. J Am Med Assoc. 1990;263(17):2341–2343
8. Kuhl CK. Current status of breast MR imaging. Part 2. Clinical applications. Radiology. 2007;244(3):672–691
   • CrossRef
9. Gokalp G, Topal U. MR imaging in probably benign lesions (BI-RADS category 3) of the breast. Eur J Radiol. 2006;57(3):436–444
   • CrossRef
10. Moy L, Elias K, Patel V, et al. Is breast MRI helpful in the evaluation of inconclusive mammographic findings?. Am J Radiol. 2009;193(4):986–993
11. Bluemke DA, Gatsonis CA, Chen MH, et al. Magnetic Resonance Imaging of the breast prior to biopsy. J Am Med Assoc. 2004;292(22):2735–2742
12. Hrung JM, Sonnad SS, Schwartz JS, Langlotz CP. Accuracy of MR imaging in the work-up of suspicious breast lesions: a diagnostic meta-analysis. Acad Radiol. 1999;6(7):387–397
    • Abstract
    • Full-Text PDF (1469 KB)
    • CrossRef
13. Peters NH, Borel Rinkes IH, Zuithoff NP, Mali WP, Moons KG, Peeters PH. Meta-analysis of MR imaging in the diagnosis of breast lesions. Radiology 2006;246(1):116–24.
14. Kuhl CK, Schmutzler RK, Leutner CC, et al. Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results. Radiology. 2000;215(1):267–279
    • MEDLINE
15. Vassiou K, Kanavou T, Vlychou M, et al. Characterization of breast lesions with CE-MR multimodal morphological and kinetic analysis: comparison with conventional mammography and high-resolution ultrasound. Eur J Radiol. 2009;70(1):69–76
    • CrossRef
16. Sickles EA. Probably benign breast lesions: when should follow-up be recommended and what is the optimal follow-up protocol?. Radiology. 1999;213(1):11–14
    • MEDLINE
17. Akita A, Tanimoto A, Jinno H, Kameyama K, Kuribayashi S. The clinical value of bilateral breast MR imaging: is it worth performing on patients showing suspicious microcalcifications on mammography?. Eur Radiol. 2009;19(9):2089–2096
    • CrossRef
18. Cilotti A, Iacconi C, Marini C, et al. Contrast-enhanced MR imaging in patients with BI-RADS 3–5 microcalcifications. Radiol Med. 2007;112(2):272–286
    • MEDLINE
    • CrossRef
19. Uematsu T, Yuen S, Kasami M, Uchida Y. Dynamic contrast-enhanced MR imaging in screening detected microcalcification lesions of the breast: is there any value?. Breast Cancer Res Treat. 2007;103(3):269–281
    • MEDLINE
    • CrossRef
20. Ciatto S, Houssami N, Apruzzese A, et al. Reader variability in reporting breast imaging according to BI-RADS assessment categories (the Florence experience). Breast. 2006;215(1):44–51